GlaxoSmithKline reports Q3 results, boost FY21 outlook

seekingalpha2021-10-27

GlaxoSmithKline(NYSE:GSK): Q3 Non-GAAP EPS of £0.37; GAAP EPS of £0.23. Revenue of £9.1B (+5% Y/Y) Sales growth across Pharmaceuticals, Vaccines and Consumer Healthcare driven by strong commercial ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Winyss10
2021-10-27
Winyss10
latest
kwkw
2021-10-27
kwkw
Like pls
- LimHanYuan回复JemLIm:
  .
- JemLIm:
  ok
- S土豪熊貓G:
  Ok
ValAly
2021-10-27
ValAly
Like
- S土豪熊貓G:
  Ok
plasticbag
2021-10-27
plasticbag
Ok
- ValAly:
  Like
- plasticbag:
  ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1192607469?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-27 19:29","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1192607469","market":"us","top_or_hot":-1,"title":"GlaxoSmithKline reports Q3 results, boost FY21 outlook","media":"seekingalpha","content":"<div>\n<p>GlaxoSmithKline(NYSE:GSK): Q3 Non-GAAP EPS of £0.37; GAAP EPS of £0.23.\nRevenue of £9.1B (+5% Y/Y)\nSales growth across Pharmaceuticals, Vaccines and Consumer Healthcare driven by strong commercial ...</p>\n\n<a href=\"https://seekingalpha.com/news/3758818-glaxosmithkline-reports-q3-results-boost-fy21-outlook\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GlaxoSmithKline reports Q3 results, boost FY21 outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlaxoSmithKline reports Q3 results, boost FY21 outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-27 19:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3758818-glaxosmithkline-reports-q3-results-boost-fy21-outlook><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GlaxoSmithKline(NYSE:GSK): Q3 Non-GAAP EPS of £0.37; GAAP EPS of £0.23.\nRevenue of £9.1B (+5% Y/Y)\nSales growth across Pharmaceuticals, Vaccines and Consumer Healthcare driven by strong commercial ...</p>\n\n<a href=\"https://seekingalpha.com/news/3758818-glaxosmithkline-reports-q3-results-boost-fy21-outlook\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK","symbol_name":"葛兰素史克","start_time":0,"source_url":"https://seekingalpha.com/news/3758818-glaxosmithkline-reports-q3-results-boost-fy21-outlook","article_id":"1192607469","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192607469","pubTimestamp":1635334185,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"GlaxoSmithKline(NYSE:GSK): Q3 Non-GAAP EPS of £0.37; GAAP EPS of £0.23.\nRevenue of £9.1B (+5% Y/Y)\nS","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GSK":"葛兰素史克"},"translate_title":"葛兰素史克公布第三季度业绩，提振21财年展望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK":0.9},"content_text":"GlaxoSmithKline(NYSE:GSK): Q3 Non-GAAP EPS of £0.37; GAAP EPS of £0.23.\nRevenue of £9.1B (+5% Y/Y)\nSales growth across Pharmaceuticals, Vaccines and Consumer Healthcare driven by strong commercial execution and underlying demand\nPharmaceuticals £4.4 billion +5% AER, +10% CER with growth in New and Specialty medicines +24% CER; Respiratory +33% CER; Immuno-inflammation +32% CER ex-COVID-19 solutions; Oncology +34% CER; total HIV +8% CER • Vaccines £2.2 billion +7% AER, +13% CER with Shingrix £502 million +41% CER\nCOVID-19 solutions sales £209 million; Xevudy £114 million and pandemic adjuvant £94 million\nConsumer Healthcare £2.5 billion +3% AER, +8% CER (+10% excluding divestments/brands under review)\n2021 EPS guidance improved and reconfirm 2022 outlook • Now expect 2021 Adjusted EPS to decline between -2% to -4% at CER excluding COVID-19 solutions, previously mid-to-high single digit decline\nNow expect 2021 Adjusted EPS contribution from COVID-19 solutions of 7% to 9% at CER\nExpectation for meaningful improvement in revenues and margins in 2022 reconfirmed\n2022 outlook excludes any contribution from COVID-19 solutions.\nDividend of 19p declared for Q3 2021. Continue to expect 80p/share for 2021","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":855310904,"gmtCreate":1635335212931,"gmtModify":1635335303014,"author":{"id":"3576987369058453","authorId":"3576987369058453","name":"Winyss10","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"latest","listText":"latest","text":"latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855310904","repostId":1192607469,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":855336523,"gmtCreate":1635334518490,"gmtModify":1635334518490,"author":{"id":"4096539860875570","authorId":"4096539860875570","name":"kwkw","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/855336523","repostId":1192607469,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6344459,"gmtCreate":1635335094616,"gmtModify":1635335094746,"authorId":3586746976587641,"author":{"id":3586746976587641,"authorId":3586746976587641,"name":"LimHanYuan","avatar":"https://static.tigerbbs.com/f0908186a4ae8902abf447739bc9ac23","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3574813808924805,"repliedAuthor":{"id":3574813808924805,"authorId":3574813808924805,"name":"JemLIm","avatar":"https://static.tigerbbs.com/ee9608155c1d123b0bf9fc773916aac7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":855336523,"type":1,"supId":6344417,"prevId":6344451,"content":".","text":".","html":"."},{"id":6344451,"gmtCreate":1635335034900,"gmtModify":1635335034937,"authorId":3574813808924805,"author":{"id":3574813808924805,"authorId":3574813808924805,"name":"JemLIm","avatar":"https://static.tigerbbs.com/ee9608155c1d123b0bf9fc773916aac7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855336523,"type":1,"supId":6344417,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":6344417,"gmtCreate":1635334760866,"gmtModify":1635334760897,"authorId":3578811676095048,"author":{"id":3578811676095048,"authorId":3578811676095048,"name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855336523,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":855336058,"gmtCreate":1635334366489,"gmtModify":1635334366656,"author":{"id":"3562707747643111","authorId":"3562707747643111","name":"ValAly","avatar":"https://static.tigerbbs.com/9d97b7d80605b322b36bcb7e5b0dff4f","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855336058","repostId":1192607469,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6344420,"gmtCreate":1635334774941,"gmtModify":1635334774974,"authorId":3578811676095048,"author":{"id":3578811676095048,"authorId":3578811676095048,"name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855336058,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":855338240,"gmtCreate":1635334303586,"gmtModify":1635334303687,"author":{"id":"3585042599146244","authorId":"3585042599146244","name":"plasticbag","avatar":"https://static.tigerbbs.com/75759bfc97d94798a8f93df583a58523","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/855338240","repostId":1192607469,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6344380,"gmtCreate":1635334373286,"gmtModify":1635334373386,"authorId":3562707747643111,"author":{"id":3562707747643111,"authorId":3562707747643111,"name":"ValAly","avatar":"https://static.tigerbbs.com/9d97b7d80605b322b36bcb7e5b0dff4f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855338240,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"},{"id":6344375,"gmtCreate":1635334307594,"gmtModify":1635334307682,"authorId":3585042599146244,"author":{"id":3585042599146244,"authorId":3585042599146244,"name":"plasticbag","avatar":"https://static.tigerbbs.com/75759bfc97d94798a8f93df583a58523","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":855338240,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":27,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192607469"}